A Multicentre Italian Trials in Ovarian Cancer (MITO) study showing the effects of a specific molecule on ovarian cancer has been named one of the best research studies presented at the American Society of Clinical Oncology (ASCO). The study showed how the addition of a specific molecule to chemotherapy in patients suffering from an advanced stage of ovarian cancer can significantly slow the progression of the disease.
The study, partially funded by the Associazione Italiana per la Ricerca sul Cancro (AIRC) and the Associazione Italiana di Oncologia Medica (AIOM), involved 80 Italian and foreign centers and was coordinated by the Istituto Nazionale Tumori Pascale di Napoli.
SOURCE: http://www.ansa.it
Dennis Palumbo is a thriller writer and psychotherapist in private practice. He's the auth...
Arnaldo Trabucco, MD, FACS is a leading urologist who received his medical training at ins...
You can tell she fills with excitement when she has the chance to show an important archae...
AGENDA 12.00 – 12.15 Light lunch12.15 – 12.30Welcome addresses Lorenzo Mannelli, MD, PhD...
by Claudia Astarita The food farming sector is still one of the engines of Italia...
A volcano near Rome thought to be extinct appears to be waking up and entering a new erupt...
The “Lovers of Modena”, a pair of skeletons so called because they were buried hand-in-han...
The Italian rail infrastructure administrator Ferrovie dello Stato Italiane has unveiled i...